title: Quality of life aspects of patients with psoriasis using a series of herbal products.
abstract: Psoriasis is a chronic inflammatory disease affecting 1-3% of the general population. Due to the chronic nature of the disease, patients suffer from substantial psychosocial impact and impaired quality of life. Dr Michaels® (also branded as Soratinex®), an Australian series of topical herbal products, has been showing promising results for the treatment of patients with chronic plaque psoriasis and consequent improvement in their quality of life. This study aims to access the changes in quality of life of patients with Psoriasis using an Australian series of herbal skin-care products Dr Michaels® (Soratinex®) for psoriasis. The aim of this study is to observe and analyze the impact of Dr Michaels® product family on the quality of life of patients with psoriasis, 566 patients completed the Dermatology Quality of Life Index (DQLI) questionnaire in their initial consultation and at 3 follow up consultations, over a 6 months period. At the end of the data collection, all patients answers were recorded and analyzed. The Psoriasis Area and Severity (PASI) Index were used to measure the severity and extent of psoriasis during the 3 consultations. The PASI for severe, moderate-severe, mild-moderate cases across time revealed a significant effect of the treatment within weeks, confirming the decreasing scores during the treatment. As well as PASI results, the final DLQI score showed a sensible reduction from mean =6.716 (at week 0) to 6.252 (at week 2), 4.015 (at week 6) and 2.407 (at week 10) signifying a 64.2% reduction of the initial score. This study demonstrates that Dr. Michaels® (Soratinex®) products, an Australian series of herbal-based skin products is effective for the treatment of psoriasis. This treatment also significantly improves patients quality of life.
authors: Department of Dermatology and Cutaneous Surgery, Department of Psychiatry and Behavioral Sciences, Institute for Bioethics and Health Policy, University of Miami, Miller School of Medicine, Miami, FL, USA; Centro Studi per la Ricerca Multidisciplinare e Rigenerativa, Università Degli Studi "G. Marconi", Rome, Italy.
authors: K
authors: K
authors: França
authors: Psoriasis and Skin Clinic, Melbourne, Australia.
authors: M
authors: M
authors: Tirant
authors: 2nd Medical Faculty, Charles University, Bulovka Hospital, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.
authors: J
authors: J
authors: Hercogovấ
authors: PRO SANUM Ltd, Sanatorium of Prof. Novotný, Štěpánská Prague 1, Czech Republic.
authors: F
authors: F
authors: Novotny
authors: Department of Nuclear Physics, Sub-nuclear and Radiation, G. Marconi University, Rome, Italy.
authors: M
authors: M
authors: Fioranelli
authors: Dermatological Department University of Pisa, Pisa, Italy.
authors: S
authors: S
authors: Gianfaldoni
authors: Onkoderma-Policlinic for dermatology and dermatologic surgery, Sofia, Bulgaria; Department of Dermatology and Venereology, Medical University of Plovdiv, Medical faculty, Plovdiv, Bulgaria.
authors: A A
authors: AA
authors: Chokoeva
authors: Medical Institute of Ministry of Interior (MVR), Department of Dermatology, Venereology and Dermatologic Surgery, Sofia, Bulgaria.
authors: G
authors: G
authors: Tchernev
authors: Department of Dermatology and Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Dresden, Germany.
authors: U
authors: U
authors: Wollina
authors: University B.I.S. Group of Institutions, Punjab Technical University, Punjab, India.
authors: M G
authors: MG
authors: Roccia
authors: Chair of Dermatology, University of Rome G. Marconi Rome, Italy.
authors: T
authors: T
authors: Lotti
mesh_terms: D001315:Australia; D006801:Humans; D011565:Psoriasis / Q000523:psychology* / Q000628:therapy*; D011788:Quality of Life; D017592:Skin Care / Q000379:methods*; D016896:Treatment Outcome